发明名称 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
摘要 This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
申请公布号 US8796422(B2) 申请公布日期 2014.08.05
申请号 US201313962110 申请日期 2013.08.08
申请人 Morehouse School of Medicine 发明人 Lillard, Jr. James W.
分类号 C07K1/00;C12P21/08;C07K16/28;A61K38/00 主分类号 C07K1/00
代理机构 Andrews Kurth LLP 代理人 Wang Ping;Andrews Kurth LLP
主权项 1. An isolated chemokine-immunoglobulin fusion polypeptide, comprising: a CCL2 moiety and an immunoglobulin moiety comprising a constant region of a human immunoglobulin wherein when the chemokine-immunoglobulin fusion polypeptide comprises an amino acid sequence selected from the group consisting of SEQ ID NO:52, SEQ ID NO:53 and SEQ ID NO:54.
地址 Atlanta GA US